Trim 40% SBUX exposure in tranches, cap residual at ≤1% with stop at $97.60
Underweight rating on SBUX with 40% trim is the optimal disposition—it balances the confirmed bearish technical setup (200-SMA break, MACD widening negative, RSI sub-32) against franchise-floor absorption (40K stores, 170M Rewards, $3B+ FCF, dividend never cut), Japan-deal optionality (~$2.5-3B cash infusion), and Q4 binary convexity; the 60% residual preserves these asymmetric upside scenarios while the $97.60 stop and ≤1% cap manage downside risk through the earnings event.
| Position | Action |
|---|---|
| Market execution at ~$94.86 | Trim initial 20% of SBUX long exposure |
| Relief rally into $97.60 or failed-bounce setup | Trim additional conditional 20% of SBUX long exposure |
| Residual position | Stop on residual at $97.60 close |
| Through Q4 FY26 earnings | Cap residual at ≤1% portfolio weight |
| Close below $93.50 on volume OR Q4 miss with guidance cut | Full liquidation within 2 trading sessions |
Starbucks is being mispriced because the market is over-discounting cyclical noise and under-pricing structural improvement, presenting a generational entry point for a category-defining brand with $3B+ FCF, a 2.65% covered dividend, and a credible turnaround already underway.
| Indicator | Value | Signal |
|---|---|---|
| close | $94.86 | neutral |
| close_10_ema | $96.13 | bearish |
| close_50_sma | $103.01 | bearish |
| close_200_sma | $97.59 | bearish |
| rsi | 31.79 | neutral |
| macd | -2.88 | bearish |
| macd_signal | -2.36 | bearish |
| macd_histogram | -0.52 | bearish |
| boll_midline | $99.77 | bearish |
| boll_upper_band | $109.42 | bearish |
| boll_lower_band | $90.13 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Cash infusion realization
Then: ~$2.5-3B binary event provides additional catalyst
↩ rebuts: “Bearish revenue narrative”
EV: +5% to +14% · concedes: SBUX has had a rough month; Technicals are challenged; The macro is hostile
SBUX is a value trap, not a generational entry—the stock is being correctly repriced for deteriorating fundamentals, and the risk/reward is asymmetric to the downside given macro tightening, inflated comps, and a premium valuation with no margin of safety.
→ vs conservative: Calls the 2.65% dividend yield a "trap door" not a floor, citing negative book equity, 0.76 current ratio, and revenue contraction—dividend is paid from FCF generated by overstated organic comps that will deteriorate once closure boosts roll off
→ vs conservative: Calls the "macro is priced in because stock is down 13% in a month" assumption "dangerous"—10-year yield at 2007 highs, Polymarket 97% odds of no cuts in 2026, and if yields rise 20-30 bps more, stock opens to 77-78 zone (another 17% downside not being priced)
→ vs conservative: Calls the "don't sell at lows" thesis wrong—highest-quality risk-adjusted sells are confirmed breakdowns; waiting turns "5% drawdown into 25% drawdown"; "yielding-to-gravity approach is what underperforms"
→ vs neutral: Calls the "mixed signals" characterization incorrect—declares the tape, macro, and fundamentals are "all pointing the same direction"; RSI at 31.79, MACD widening negative, price below all moving averages is "unambiguously bearish"
→ vs neutral: Disputes the "one-time" charge framing—Q3 2025 $755M charge was similarly dismissed and stock was "crushed for months" after; $300M restructuring is part of CEO Niccol's multi-year reset, not an isolated event
→ vs neutral: Questions the "patience" thesis—waiting for "clarity" means becoming a "forced seller later at a worse price"; the current 5-to-1 setup is already a high-probability asymmetric trade
| bearish |
| atr | $2.23 | neutral |
Support: 93.5 · 90.13 · 87 · 88 | Resistance: 96.13 · 97.59 · 99.8 · 103 · 108.5
SBUX exhibits a firmly bearish technical setup with all major moving averages stacked below price (10-EMA $96.13, 50-SMA $103.01, 200-SMA $97.59), confirming the downtrend. Momentum indicators are deeply negative with MACD histogram at -0.52 and widening, while RSI at 31.79 approaches but hasn't breached the classic oversold threshold of 30. The stock closed at $94.86 on 2026-09-25 after falling from the August peak of $108.49, with the Bollinger lower band at $90.13 representing the immediate downside target. A tactical bounce toward $97-99 is possible given oversold conditions, but the path of least resistance remains lower until price reclaims the 10-EMA ($96.13) on a closing basis.
Market Cap
$108.1B
Share Price
$94.89
P/E (TTM)
54.8x
Forward P/E
30.4x
EPS (TTM)
$1.73
Forward EPS
$3.12
PEG Ratio
1.11
Dividend Yield
2.65%
Beta
0.97
Revenue (TTM)
$38.34B
Gross Profit
$8.57B
EBITDA
$5.64B
Net Income (TTM)
$1.98B
Free Cash Flow
$3.07B
Book Value / Share
–$6.73
Total Debt
$22.43B
Cash & Equivalents
$3.45B
Net Debt
$9.83B
Stockholders' Equity
–$7.67B
Current Ratio
0.76
Working Capital
–$2.38B
Capital Lease Obligations
$9.16B
Goodwill
$1.24B
Net PPE
$14.97B
Long-Term Debt
$11.78B
Operating Margin (TTM)
12.9%
Gross Margin
~22.3%
Net Margin
5.2%
50-Day MA
$103.52
200-Day MA
$98.43
Q2 2026 Revenue
$9.32B
Q2 2026 EPS
$0.91
Q2-26 Operating Cash Flow
$1.64B
Q2-26 Free Cash Flow
$1.35B
Q2-26 CapEx
$291M
Quarterly Dividends
~$706M
Q2-26 Net Business Sale
$2.54B
Q2-26 Debt Repayment
$1.82B
Buybacks
Suspended
Strengths
Concerns
Starbucks is in the middle of a major operational restructuring phase with $2.54B in divestiture proceeds being used to aggressively deleverage from $13.55B to $9.83B in net debt. The headline TTM EPS of $1.73 is heavily distorted by a $536M one-time gain in Q2-26 and restructuring charges in prior quarters; underlying normalized earnings are estimated at $2.20–$2.50/share annualized. At 54.8x TTM P/E the stock is priced for significant recovery, though the forward P/E of 30.4x provides a more reasonable entry point if management can deliver on the projected $3.12 EPS recovery. The 2.65% dividend yield is well-supported by $3.07B in annual free cash flow and appears sustainable even in a downturn scenario. Structural balance sheet concerns remain including negative stockholders' equity of –$7.67B and a sub-1.0 current ratio of 0.76, though the deleveraging trajectory is positive. Revenue softness in Q2-26 ($9.32B, down from $9.92B peak) and margin compression (COGS at ~75%) warrant monitoring of same-store sales trends.
Macro: The dominant macro story is a bond rout with long-end Treasury yields at multi-decade highs (10Y at 2007 levels, 30Y at 2004 levels) and markets now pricing in another Fed rate hike rather than cuts. Polymarket assigns 97% probability to no Fed cuts in 2026. Mortgage rates are creeping toward 7.5%, signaling real housing-market stress. US recession odds are 10% (+1.0pp on the week), with UK recession odds jumping sharply to 14%. A Trump–Xi dinner provided mild relief for China-exposed names like SBUX. Despite the bond rout, equity markets (Dow/S&P/Nasdaq) nailed weekly wins on Friday — a partial relief rally, but small-caps and long-duration names getting hit hardest.